State Government Agencies

In this video CDC's Dr. LoBue discussing the updated recommendations for the 12-dose treatment regimen for latent TB infection.

A new report from the National Academy of Public Administration that makes the case for taking urgent, concrete action to address skyrocketing STDs in the United States.

This report provides an overview of high-risk HIV behaviors among women ages 18–44 in the United States, based on national surveillance data from the Behavioral Risk Factor Surveillance System (BRFSS). High-risk behaviors include injecting non-prescribed drugs, receiving treatment for a sexually transmitted infection, and exchanging sex for money or drugs within the past year. These behaviors are key indicators of HIV vulnerability and often reflect broader social and structural factors such as access to health care, substance use patterns, and economic instability.

This toolkit delivers updated data visualizations, infographics, and social media assets spotlighting the intersection of viral hepatitis and the opioid crisis—highlighting regional opioid prescribing rates alongside Hepatitis C mortality trends to support awareness campaigns during Hepatitis Awareness Month.

This guideline provides comprehensive, evidence-based recommendations on prophylaxis, treatment, immunization, and drug interactions for a wide range of pediatric OIs—including new additions for coccidioidomycosis, hepatitis B revaccination, and updated immunization schedules—to guide clinicians caring for HIV‑exposed and infected children.

This guideline offers updated, evidence-based recommendations—from preconception through postpartum—on universal prenatal HIV testing, preferred antiretroviral regimens (e.g., bictegravir/TAF/FTC), maternal viral monitoring, obstetric management, and neonatal prophylaxis to further reduce perinatal HIV transmission toward elimination goals (defined as <1% transmission rate and <1 infection per 100,000 live births).

This information sheet offers an in-depth analysis of current AFP models—including funding mechanisms, stakeholder roles, and implementation strategies—to support sustainability of HIV-related services beyond traditional grant funding. It outlines key considerations and best practices to help health departments and community partners explore and launch innovative financing options for long-term epidemic response planning.

This toolkit supports Ryan White HIV/AIDS Program (RWHAP) Part B AIDS Drug Assistance Programs (ADAPs)—which provide access to HIV-related medications for low-income individuals—in navigating the planning, selection, and implementation of benefits management contracts. It offers key definitions, planning tools, real-world examples, and checklists to help ADAP administrators—new or experienced—align contractor selection with their program’s unique infrastructure and needs.